NEW YORK (
Medicis Pharmaceuticals Corporation
) hit a new 52-week high Monday as it traded at $31.81 compared with its previous 52-Week high of $30.94. Medicis is changing hands at $31.40 with 389,471 shares traded as of 9:31 a.m. ET. Average volume has been 800,600 shares over the past 30 days.
Medicis has a market cap of $1.5 billion and is part of the
industry. Shares are down 3.6% year to date as of the close of trading on Friday.
Medicis Pharmaceutical Corporation, a specialty pharmaceutical company, engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. The company has a P/E ratio of 11.9, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 22.6.
TheStreet Ratings rates Medicis as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
52-week high stocks
or get investment ideas from our